SEC Form 4 · accession 0001144204-17-034654
Edesa Biotech, Inc. · EDSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel E. Morse
Director
Period of report
Jun 26, 2017
Accepted (ET)
Jun 28, 2017 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001540159
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par valueF1 | Jun 26, 2017 | A | 134,680 | $0.00 | A | 231,189 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued under the issuer's Performance Share Plan.